Disease-modifying Therapy in Vasculitides

Herausgegeben:Kallenberg, Cees G.M.; Cohen Tervaert, Jan W.

• Broschiertes Buch

Produktbeschreibung

Especially the past two decades have seen renewed interest in thevasculitides. In this volume an international expert group presents thecurrent state of knowledge and concentrates on principles of immunemodulating therapy. Drawing from their work in rheumatology, nephrology,internal medicine, connective tissue disease and clinical immunology,they present new concepts in classificiation, diagnosis andpathophysiology of the vasculitides. Evidence from experimental andclinical trials is reviewed, as well as the outlook for furtherresearch.

Produktdetails

• Progress in Inflammation Research
• Verlag: Birkhäuser / Birkhäuser Basel / Springer, Basel
• Artikelnr. des Verlages: 978-3-0348-9485-2
• Softcover reprint of the original 1st ed. 2001
• Seitenzahl: 220
• Erscheinungstermin: 23. Oktober 2012
• Englisch
• Abmessung: 235mm x 155mm x 13mm
• Gewicht: 341g
• ISBN-13: 9783034894852
• ISBN-10: 3034894856
• Artikelnr.: 39522850

Inhaltsangabe

Systemic vasculitides, an introduction.- Standard therapeutic regimens for vasculitis.- Tumor necrosis factor (TNF) inhibition in the treatment of vasculitis.- Methotrexate as an alternative to classic immunosuppressive therapies.- Intravenous immunoglobulin as immuno-modifying treatment.- T-cell directed treatment: anti-thymocyte globulin.- New immunosuppressants: mycophenolate mofetil and 15-deoxyspergualin.- Interferon-? for the treatment of virus-related systemic vasculitides.- Autologous stem cell therapy for systemic vasculitis.- Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody related necrotizing small-vessel vasculitis: the role for autoantibody guided and anti-bacterial treatment.